{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-009928","form_type":"8-K","ticker":"MGX","cik":"0001785279","company_name":"Metagenomi Therapeutics, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.169514+00:00","generated_at":"2026-05-16T10:55:05.641210+00:00","sec_items":["5.03","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Metagenomi renames to Metagenomi Therapeutics; hemophilia A program on track for IND in 2026","bullets":["Name changed to Metagenomi Therapeutics, Inc. effective Jan 12, 2026; ticker MGX unchanged.","Lead program MGX-001: pre-IND meeting completed; IND/CTA on track for Q4 2026.","Preclinical data showed curative FVIII activity in NHPs with no off-target editing.","Cash runway extended to Q4 2027 following strategic pipeline prioritization.","Jian Irish appointed CEO as part of strategic evolution toward in vivo gene editing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-009928","json":"https://secwatch.observer/filing/0001193125-26-009928.json","markdown":"https://secwatch.observer/filing/0001193125-26-009928.md","text":"https://secwatch.observer/filing/0001193125-26-009928.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1785279/000119312526009928/0001193125-26-009928-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1785279/000119312526009928/mgx-20260112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:55:05.641210+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4e080e3afe3adaf957bb43e36b44a18f519e7c4e","claim":"Metagenomi Therapeutics, Inc.: Amended certificate of incorporation to change company name from Metagenomi, Inc. to Metagenomi Therapeutics, Inc (effective 2026-01-12).","evidence_excerpt":"filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312526009928/0001193125-26-009928-index.htm","confidence":0.9},{"claim_id":"89d2a51d8baac8668600fc2870c3e636f1754151","claim":"Metagenomi Therapeutics, Inc.: Amended and restated bylaws solely to reflect the name change (effective 2026-01-12).","evidence_excerpt":"the Company’s Board also amended and restated its Amended and Restated Bylaws (as amended, the “Second Amended and Restated Bylaws”), effective on January 12, 2026, solely to reflect the Name Change.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312526009928/0001193125-26-009928-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001193125-26-245505","ticker":"PRHI","company_name":"Presurance Holdings, Inc.","filed_at":"2026-05-28T21:10:02+00:00","headline":"Presurance Holdings announces 1-for-7 reverse stock split to meet Nasdaq listing requirements","event_type":"other_material","sec_items":["3.03","5.03","7.01","8.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-245505","json":"https://secwatch.observer/filing/0001193125-26-245505.json","markdown":"https://secwatch.observer/filing/0001193125-26-245505.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1502292/000119312526245505/0001193125-26-245505-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1502292/000119312526245505/prhi-20260528.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312526009928/0001193125-26-009928-index.htm","comparable_excerpt":"On May 28, 2026, the Company filed with the Secretary of State of the State of Michigan (the “Michigan Secretary of State”) a Certificate of Amendment to its Articles of Incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1502292/000119312526245505/0001193125-26-245505-index.htm"}},{"accession":"0001731122-26-000782","ticker":"SDOT","company_name":"Sadot Group Inc.","filed_at":"2026-05-22T12:30:32+00:00","headline":"Sadot Group announces 1-for-20 reverse stock split to meet Nasdaq $1 minimum bid price","event_type":"other_material","sec_items":["3.03","5.03","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-26-000782","json":"https://secwatch.observer/filing/0001731122-26-000782.json","markdown":"https://secwatch.observer/filing/0001731122-26-000782.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1701756/000173112226000782/0001731122-26-000782-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1701756/000173112226000782/e7665_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312526009928/0001193125-26-009928-index.htm","comparable_excerpt":"On May 22, 2026, the Company filed a Certificate of Change Pursuant to NRS 78.209 with the Nevada Secretary of State to effect the Reverse Stock Split, which will become effective 12:01 a.m. eastern on May 27, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1701756/000173112226000782/0001731122-26-000782-index.htm"}},{"accession":"0001062993-26-002388","ticker":"WAMFF","company_name":"Alaska Silver Corp.","filed_at":"2026-05-07T23:59:59+00:00","headline":"Alaska Silver simplifies capital structure, eliminates dual-class shares","event_type":"other_material","sec_items":["3.03","5.03","7.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-26-002388","json":"https://secwatch.observer/filing/0001062993-26-002388.json","markdown":"https://secwatch.observer/filing/0001062993-26-002388.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1893899/000106299326002388/0001062993-26-002388-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1893899/000106299326002388/form8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312526009928/0001193125-26-009928-index.htm","comparable_excerpt":"On May 6, 2026, the Board of Directors of Alaska Silver Corp. (the \"Company\"), approved an amendment (the \"Amendment\") to the Company's Articles of the Company to eliminate its dual-class share structure by (i) eliminating its proportionate voting share class and (ii) reidentifying its subordinate voting share class as the class of \"Common Shares,\" no par value, of which the Company shall be authorized to issue an unlimited number of Common Shares.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1893899/000106299326002388/0001062993-26-002388-index.htm"}},{"accession":"0001104659-26-057200","ticker":"CUK","company_name":"CARNIVAL PLC","filed_at":"2026-05-07T23:59:59+00:00","headline":"Carnival completes DLC unification and redomiciliation to Bermuda; Carnival plc now a subsidiary","event_type":"other_material","sec_items":["1.02","2.01","3.01","3.02","3.03","5.01","5.03","7.01","9.01"],"materiality_score":0.7,"calibrated_materiality_score":0.7,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 7.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-057200","json":"https://secwatch.observer/filing/0001104659-26-057200.json","markdown":"https://secwatch.observer/filing/0001104659-26-057200.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1125259/000110465926057200/0001104659-26-057200-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/815097/000110465926057200/tm2613680d1_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312526009928/0001193125-26-009928-index.htm","comparable_excerpt":"In addition, Carnival Corporation also migrated its jurisdiction of incorporation from the Republic of Panama to Bermuda and changed its name to \"Carnival Corporation Ltd.\" (the \"Redomiciliation\" and, together with the DLC Unification, the \"DLC Unification and Redomiciliation Transactions\").","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1125259/000110465926057200/0001104659-26-057200-index.htm"}},{"accession":"0001628280-26-039465","ticker":"IOT","company_name":"Samsara Inc.","filed_at":"2026-06-01T20:07:41+00:00","headline":"Samsara Inc. reincorporates from Delaware to Nevada, effective June 1, 2026","event_type":"other_material","sec_items":["3.03","5.03","9.01"],"materiality_score":0.45,"calibrated_materiality_score":0.45,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039465","json":"https://secwatch.observer/filing/0001628280-26-039465.json","markdown":"https://secwatch.observer/filing/0001628280-26-039465.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642896/000162828026039465/0001628280-26-039465-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642896/000162828026039465/iot-20260601.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312526009928/0001193125-26-009928-index.htm","comparable_excerpt":"the reincorporation of the Company from the State of Delaware to the State of Nevada (the “Reincorporation”) became effective on June 1, 2026, at 12:02 a.m. Pacific Time","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1642896/000162828026039465/0001628280-26-039465-index.htm"}},{"accession":"0000943374-26-000219","ticker":"DCOM","company_name":"Dime Community Bancshares, Inc. /NY/","filed_at":"2026-06-01T20:02:33+00:00","headline":"Dime Commercial Bancshares name change effective; three executives amend employment agreements","event_type":"other_material","sec_items":["5.02","5.03","5.07","9.01"],"materiality_score":0.55,"calibrated_materiality_score":0.55,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000943374-26-000219","json":"https://secwatch.observer/filing/0000943374-26-000219.json","markdown":"https://secwatch.observer/filing/0000943374-26-000219.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/846617/000094337426000219/0000943374-26-000219-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/846617/000094337426000219/form8k_052826.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312526009928/0001193125-26-009928-index.htm","comparable_excerpt":"On May 28, 2026, the Company filed with the Department of State of the State of New York a Certificate of Amendment to Certificate of Incorporation to change our corporate name from Dime Community Bancshares, Inc. to Dime Commercial Bancshares, Inc., effective immediate.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/846617/000094337426000219/0000943374-26-000219-index.htm"}},{"accession":"0001437749-26-018930","ticker":"CPSH","company_name":"CPS TECHNOLOGIES CORP/DE/","filed_at":"2026-06-01T13:35:50+00:00","headline":"CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share","event_type":"other_material","sec_items":["1.01","5.03","8.01","9.01"],"materiality_score":0.6,"calibrated_materiality_score":0.6,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-018930","json":"https://secwatch.observer/filing/0001437749-26-018930.json","markdown":"https://secwatch.observer/filing/0001437749-26-018930.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/0001437749-26-018930-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/cpsh20260528_8k.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312526009928/0001193125-26-009928-index.htm","comparable_excerpt":"On May 27, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the “Amendment”) of the Company’s Restated Certificate of Incorporation, effective as of the same date. The Amendment increased the number of shares of common stock, $0.01 par value per share (the “Common Stock”), that the Company is authorized to issue from 20,000,000 to 25,000,000.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/814676/000143774926018930/0001437749-26-018930-index.htm"}},{"accession":"0001213900-26-063110","ticker":"RDAC","company_name":"Rising Dragon Acquisition Corp.","filed_at":"2026-06-01T10:08:35+00:00","headline":"Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed","event_type":"other_material","sec_items":["1.01","5.03","5.07","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same fact type: governance_change","same SEC item: 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063110","json":"https://secwatch.observer/filing/0001213900-26-063110.json","markdown":"https://secwatch.observer/filing/0001213900-26-063110.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/0001213900-26-063110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/ea0292895-8k_rising.htm"},"side_by_side_evidence":{"fact_type":"governance_change","source_excerpt":"filed a certificate of amendment to its Amended and Restated Certificate of Incorporation (the “Certificate of Incorporation”), solely to change the Company’s name from “Metagenomi, Inc.” to “Metagenomi Therapeutics, Inc.” (the “Name Change”), which became effective at 12:01 a.m. Pacific Time on January 12, 2026.","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1785279/000119312526009928/0001193125-26-009928-index.htm","comparable_excerpt":"Subsequent to the approval by its shareholders at the Extension Meeting of Rising Dragon’s second amended and restated memorandum and articles of association (the “Amended Charter”), the Company filed the Amended Charter with the Cayman Islands Registrar of Companies, effective May 28, 2026","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/0001213900-26-063110-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}